跳至主要内容
临床试验/NCT03871400
NCT03871400暂停不适用

Comparison of Early Fusion Using a NanoMetalene® Implant Versus Both PEEK and Allograft Implants in Anterior Cervical Discectomy and Fusion (ACDF) With OsteoStrand™ Demineralized Bone Fibers

SeaSpine, Inc.22 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2018年11月18日最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
入组人数
18
试验地点
22
主要终点
Proportion of cervical spinal levels for NanoMetalene vs PEEK interbody implants that have achieved fusion as determined by Computed Tomography (CT) analysis

研究概览

简要总结

A prospective, multi-center, randomized, self-controlled, single-blinded, clinical study evaluating the NanoMetalene implant as compared to the PEEK and allograft implants in ACDF for the treatment of cervical degenerative disc disease (DDD).

详细描述

PEEK: Polyetheretherketone ACDF: Anterior cervical discectomy and fusion

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cervical degenerative disc disease
  • Requires primary spinal fusion from C3-C7
  • Minimum of 6 weeks of non-operative treatment
  • Signed informed consent form

排除标准

  • Uncontrolled type I or II diabetes mellitus
  • Morbid obesity
  • Documented history of alcohol or drug abuse
  • Fever or leukocytosis
  • Current systemic infection
  • Active malignancy and/or current chemotherapy
  • Known history of osteoporosis
  • Prior fusion or total disc replacement at the operative level or an adjacent level
  • Infection of the operative site
  • Use of implants from other systems
  • Pregnancy
  • Participation in another research study

结局指标

主要结局

Proportion of cervical spinal levels for NanoMetalene vs PEEK interbody implants that have achieved fusion as determined by Computed Tomography (CT) analysis

时间窗: 12 months

Proportion of cervical spinal levels for NanoMetalene vs PEEK interbody implants that have achieved fusion as determined by Computed Tomography (CT) analysis

次要结局

  • Secondary CT Analysis: PEEK(12 months)
  • Secondary CT Analysis: Allograft(12 months)
  • Secondary X-Ray Analysis(24 months)
  • Clinical Outcomes: NDI(24 months)
  • Clinical Outcomes: VAS Arm(24 months)
  • Clinical Outcomes: VAS Neck(24 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验